NASDAQ:CUE | Free Cash Flow | Cue Biopharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.94M$121,000.00-$11.06M
2025-12-31-$1.08M$0.00-$1.08M-67.89%
2025-03-31-$8.17M$150,000.00-$8.32M
2024-12-31-$9.03M$2,000.00-$9.03M
2024-03-31-$9.78M$55,000.00-$9.84M
2023-12-31-$10.96M$0.00-$10.96M
2023-03-31-$10.83M$0.00-$10.83M
2022-12-31-$10.51M$1,000.00-$10.52M
2022-03-31-$11.57M$27,000.00-$11.6M
2021-12-31-$10.65M$39.00-$10.65M
2021-03-31-$11.8M$648,000.00-$12.44M
2020-12-31-$7M$108,259.00-$7.11M
2020-03-31-$10.94M
2019-12-31-$6.44M$10,353.00-$6.45M
2019-03-31-$8.48M$19,000.00-$8.49M
2018-12-31-$3.9M$120,246.00-$4.02M
2018-03-31-$9.76M$673,000.00-$10.43M
2017-12-31-$1.85M$18,942.00-$1.86M
2017-03-31-$3.46M$556,000.00-$4.02M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$21.69M$177,000.00-$21.86M
2024-12-31-$36.33M$66,000.00-$36.4M
2023-12-31-$39.96M$0.00-$39.96M
2022-12-31-$41.81M$171,000.00-$41.98M
2021-12-31-$38.84M$913,039.00-$39.75M
2020-12-31-$32.49M$595,259.00-$33.09M
2019-12-31-$30.8M$46,353.00-$30.84M
2018-12-31-$26.41M$1.85M-$28.27M
2017-12-31-$12.14M$1.03M-$13.17M